MCID: EST001
MIFTS: 24

Estrogen-Receptor Positive Breast Cancer malady

Cancer diseases category
Download this MalaCard

Summaries for Estrogen-Receptor Positive Breast Cancer

About this section
Sources:
33MalaCards
See all sources

Fully expand this MalaCard
MalaCards: Estrogen-Receptor Positive Breast Cancer is related to breast cancer and estrogen-receptor negative breast cancer. An important gene associated with Estrogen-Receptor Positive Breast Cancer is GPR152 (G protein-coupled receptor 152). Affiliated tissues include breast, lymph node and bone.

Aliases & Classifications for Estrogen-Receptor Positive Breast Cancer

About this section
Sources:
8Disease Ontology, 10DISEASES
See all sources

Classifications:

Malacards categories (disease lists): (See all malacards categories)
Global: Cancer diseases


Aliases & Descriptions:

estrogen-receptor positive breast cancer 8 10


External Ids:

Disease Ontology8 DOID:0060075

Related Diseases for Estrogen-Receptor Positive Breast Cancer

About this section
Sources:
17GeneCards, 18GeneDecks
See all sources

Diseases in the Estrogen-Receptor Positive Breast Cancer family:

Estrogen-Receptor Negative Breast Cancer

Diseases related to Estrogen-Receptor Positive Breast Cancer via text searches within MalaCards or GeneCards/GeneDecks gene sharing:

idRelated DiseaseScoreTop Affiliating Genes
1breast cancer11.5
2estrogen-receptor negative breast cancer10.6
3endotheliitis10.5
4parametritis10.3
5fallopian tube cancer10.3
6papillary thyroid carcinoma10.3
7thyroiditis10.3
8blindness10.3

Graphical network of diseases related to Estrogen-Receptor Positive Breast Cancer:



Diseases related to estrogen-receptor positive breast cancer

Symptoms for Estrogen-Receptor Positive Breast Cancer

About this section

Drugs & Therapeutics for Estrogen-Receptor Positive Breast Cancer

About this section
Sources:
42NIH Clinical Center, 6ClinicalTrials
See all sources

Drug clinical trials:

Search ClinicalTrials for Estrogen-Receptor Positive Breast Cancer

Search NIH Clinical Center for Estrogen-Receptor Positive Breast Cancer

Genetic Tests for Estrogen-Receptor Positive Breast Cancer

About this section

Anatomical Context for Estrogen-Receptor Positive Breast Cancer

About this section
Sources:
33MalaCards
See all sources

MalaCards organs/tissues related to Estrogen-Receptor Positive Breast Cancer:

33
Breast, Lymph node, Bone, Testes, Endothelial, Thyroid, T cells

Animal Models for Estrogen-Receptor Positive Breast Cancer or affiliated genes

About this section

Publications for Estrogen-Receptor Positive Breast Cancer

About this section
Sources:
52PubMed
See all sources

Articles related to Estrogen-Receptor Positive Breast Cancer:

(show top 50)    (show all 238)
idTitleAuthorsYear
1
The difference in prognostic factors between early recurrence and late recurrence in estrogen receptor-positive breast cancer: nodal stage differently impacts early and late recurrence. (23717438)
2013
2
Targeting BCL-2 with the BH3 mimetic ABT-199 in estrogen receptor-positive breast cancer. (23845444)
2013
3
Methylation of the claudin 1 promoter is associated with loss of expression in estrogen receptor positive breast cancer. (23844228)
2013
4
Tamoxifen or letrozole versus standard methods for women with estrogen-receptor positive breast cancer undergoing oocyte or embryo cryopreservation in assisted reproduction. (24213953)
2013
5
Soluble interleukin-6 receptor is a prognostic marker for relapse-free survival in estrogen receptor-positive breast cancer. (23902164)
2013
6
Insulin-like growth factor receptor polymorphism defines clinical outcome in estrogen receptor-positive breast cancer patients treated with tamoxifen. (23459444)
2013
7
Treatment of estrogen receptor-positive breast cancer. (23278394)
2013
8
Use of the neo-adjuvant exemestane in post-menopausal estrogen receptor-positive breast cancer: a randomized phase II trial (PTEX46) to investigate the optimal duration of preoperative endocrine therapy. (23587451)
2013
9
Association of tissue inhibitor of metalloproteinases-1 and Ki67 in estrogen receptor positive breast cancer. (23205744)
2013
10
Leptin as a potential target for estrogen receptor-positive breast cancer. (23843844)
2013
11
Beta-naphthoflavone (DB06732) mediates estrogen receptor-positive breast cancer cell cycle arrest through AhR-dependent regulation of PI3K/AKT and MAPK/ERK signaling. (24163404)
2013
12
Changes of tumor infiltrating lymphocyte subtypes before and after neoadjuvant endocrine therapy in estrogen receptor-positive breast cancer patients--an immunohistochemical study of Cd8+ and Foxp3+ using double immunostaining with correlation to the pathobiological response of the patients. (23280127)
2012
13
Functional variable number of tandem repeats variation in the promoter of proto-oncogene PTTG1IP is associated with risk of estrogen receptor-positive breast cancer. (22404099)
2012
14
Mouse models of estrogen receptor-positive breast cancer. (22279420)
2011
15
Estrogen-mediated upregulation of Noxa is associated with cell cycle progression in estrogen receptor-positive breast cancer cells. (22216287)
2011
16
Multi-field-of-view strategy for image-based outcome prediction of multi-parametric estrogen receptor-positive breast cancer histopathology: Comparison to Oncotype DX. (22811953)
2011
17
Shu-Gan-Liang-Xue Decoction Simultaneously Down-regulates Expressions of Aromatase and Steroid Sulfatase in Estrogen Receptor Positive Breast Cancer Cells. (23467843)
2011
18
Estrogen receptor-positive breast cancer in Japanese women: trends in incidence, characteristics, and prognosis. (21119029)
2011
19
Bisphosphonate use after estrogen receptor-positive breast cancer and risk of contralateral breast cancer. (22021667)
2011
20
Physician survey of the effect of the 21-gene recurrence score assay results on treatment recommendations for patients with lymph node-positive, estrogen receptor-positive breast cancer. (21731516)
2011
21
PRO_10--a new tissue-based prognostic multigene marker in patients with early estrogen receptor-positive breast cancer. (21613801)
2011
22
Response of estrogen receptor-positive breast cancer tumorspheres to antiestrogen treatments. (21533195)
2011
23
Understanding the estrogen receptor-positive breast cancer genome: not even the end of the beginning. (21447809)
2011
24
Preclinical modeling of combined phosphatidylinositol-3-kinase inhibition with endocrine therapy for estrogen receptor-positive breast cancer. (21362200)
2011
25
SLC6A14 (ATB0,+) protein, a highly concentrative and broad specific amino acid transporter, is a novel and effective drug target for treatment of estrogen receptor-positive breast cancer. (21771784)
2011
26
Association of FGFR2 gene polymorphism with estrogen receptor positive breast cancer detected by fluorescent quantitative PCR]. (20677155)
2010
27
Phosphatidyl-inositol-3-kinase alpha catalytic subunit mutation and response to neoadjuvant endocrine therapy for estrogen receptor positive breast cancer. (19844788)
2010
28
Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20. (20065188)
2010
29
The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells. (20086172)
2010
30
Are estrogen receptor-positive breast cancers in BRCA1 mutation carriers sporadic? (20346095)
2010
31
MRP as a new predictive marker of tamoxifen efficiency in treatment of estrogen receptor-positive breast cancer. (20380160)
2010
32
Adjuvant! Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breast cancer. (20195744)
2010
33
Estrogen-induced aurora kinase-A (AURKA) gene expression is activated by GATA-3 in estrogen receptor-positive breast cancer cells. (21761347)
2010
34
Low expression of a few genes indicates good prognosis in estrogen receptor positive breast cancer. (19619298)
2009
35
DNA methylation markers predict outcome in node-positive, estrogen receptor-positive breast cancer with adjuvant anthracycline-based chemotherapy. (19118060)
2009
36
Role of AIB1 for tamoxifen resistance in estrogen receptor-positive breast cancer cells. (18827493)
2008
37
Poor outcome in estrogen receptor-positive breast cancers predicted by loss of plexin B1. (17317819)
2007
38
Tamoxifen induces heparanase expression in estrogen receptor-positive breast cancer. (17634531)
2007
39
Progesterone receptor in estrogen receptor-positive breast cancer: the association between HER-2 and lymph node involvement is age related. (16735717)
2006
40
High expression of two genes selected by iAFLP: a new prognostic factor of estrogen receptor-positive breast cancer. (15254706)
2004
41
High expression of steroid sulfatase mRNA predicts poor prognosis in patients with estrogen receptor-positive breast cancer. (12796397)
2003
42
Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells. (12444551)
2002
43
A therapeutic target for hormone-independent estrogen receptor-positive breast cancers. (11474128)
2001
44
Induction of transforming growth factor-beta receptor type II expression in estrogen receptor-positive breast cancer cells through SP1 activation by 5-aza-2'-deoxycytidine. (9632722)
1998
45
Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer. (9390536)
1997
46
Adjuvant CMFVP versus adjuvant CMFVP plus ovariectomy for premenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study. (8558219)
1996
47
Regarding the dilemma of adjuvant therapy in postmenopausal patients with node-positive, estrogen receptor-positive breast cancer: are we better informed? (7707102)
1995
48
Influence of different combinations of tamoxifen and toremifene on estrogen receptor-positive breast cancer cell lines. (7553677)
1995
49
Cyclical use of tamoxifen and high-dose medroxyprogesterone acetate in advanced estrogen receptor positive breast cancer. (2151369)
1990
50
Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer. (7079745)
1982

Variations for Estrogen-Receptor Positive Breast Cancer

About this section

Expression for genes affiliated with Estrogen-Receptor Positive Breast Cancer

About this section
Sources:
2BioGPS, 15Gene Expression Omnibus DataSets
See all sources
Expression patterns in normal tissues for genes affiliated with Estrogen-Receptor Positive Breast Cancer

Search GEO for disease gene expression data for Estrogen-Receptor Positive Breast Cancer.

Pathways for genes affiliated with Estrogen-Receptor Positive Breast Cancer

About this section

Compounds for genes affiliated with Estrogen-Receptor Positive Breast Cancer

About this section

GO Terms for genes affiliated with Estrogen-Receptor Positive Breast Cancer

About this section

Products for genes affiliated with Estrogen-Receptor Positive Breast Cancer

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies

Sources for Estrogen-Receptor Positive Breast Cancer

About this section
4CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
29IUPHAR
30KEGG
35MeSH
36MESH via Orphanet
37MGI
40NCIt
41NDF-RT
44NINDS
45Novoseek
47OMIM
48OMIM via Orphanet
52PubMed
53QIAGEN
59SNOMED-CT via Orphanet
62UMLS
63UMLS via Orphanet